• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Older breast cancer patients in England less likely to survive

Bioengineer by Bioengineer
June 7, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands according to research published today in the British Journal of Cancer*.

In one of the largest studies of its kind looking at breast cancer patients aged 70 and over, researchers found that England ranked worst out of the selected countries for five year survival for breast cancer at stage two and three.

The team based at the Leiden University Medical Centre in The Netherlands analysed the anonymised records of 236,015 women who'd been diagnosed with breast cancer before it had spread.

They also found patients with stage one or two breast cancer in England are most likely to have no surgery as part of their treatment compared with other countries.

Not having surgery at stage three was found to be linked to poorer survival. In England 44% of patients received no surgery at stage three, compared to 22% of patients in Belgium.

Overall the number of patients with stage three breast cancer surviving their disease for five years or more in England (48%) was 12% lower than in Belgium (60%).

Author Dr Marloes Derks said: "The fact breast cancer mortality in England is higher than in other countries in this study even for those women whose cancer is in its earliest stage suggests there is something more at play than just a failure to diagnose it early.

"We were surprised to see England had lower levels of breast cancer surgery and further research is needed to establish whether these two factors are linked."

Professor Arnie Purushotham, senior clinical adviser at Cancer Research UK, said: "We know that surgery is one of the most effective treatments for breast cancer so it's vital that women in England aren't missing out on surgical treatment that could save their lives.

"We need to better understand why patients in England are less likely to have surgery than their European counterparts. Surgery should be considered in all older patients who are fit to undergo this treatment.

"While the thought of an operation might sometimes be daunting, breakthroughs in surgical techniques have meant that for many patients a lumpectomy with minimal surgery to the armpit glands can be just as effective as more radical treatment."

###

Notes to editor:

*Derks et al. Variation in treatment and survival of older patients with nonmetastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group 10.1038/s41416-018-0090-1

Post embargo link: http://www.nature.com/articles/s41416-018-0090-1

Media Contact

Emily Attwood
[email protected]
020-346-96700
@CR_UK

http://www.cancerresearchuk.org

http://dx.doi.org/10.1038/s41416-018-0090-1

Share12Tweet8Share2ShareShareShare2

Related Posts

New Open-Source Data Platform Launched to Advance Lung Cancer Genetics Research

September 8, 2025

Overcoming Resistance Mutations and the Blood–Brain Barrier: Major Challenges in Targeted Therapy for Brain Metastases in Non-Small Cell Lung Cancer

September 8, 2025

Moffitt Creates First Genetically Engineered Cancer Model in Naked Mole Rats

September 8, 2025

IU Scientists Reengineer Cancer-Protective Regulatory T Cells to Combat Tumors

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Open-Source Data Platform Launched to Advance Lung Cancer Genetics Research

AI Reveals Stress Levels in Farmed Amazonian Fish, New Study Shows

Overcoming Resistance Mutations and the Blood–Brain Barrier: Major Challenges in Targeted Therapy for Brain Metastases in Non-Small Cell Lung Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.